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Use of intracardiac devices for heart diseases is increasing worldwide. One of the important
complications of pacemakers is infective endocarditis from the leads as the source. In this
case, we report a lead endocarditis caused by Staphylococcus hominis four years after the
pacemaker implantation. A 50 year-old diabetic woman, who was implanted a permanent
pacemaker four years ago, had complaints of fever and fatigue three months ago. On
transesophageal echocardiography (TEE), a mobile mass resembling vegetation on the lead,
which was 15 10mm in diameter was revealed. At the end of the secondweek of treatment,
fever persisted and markers of inflammation remained elevated. Thus, the patient was
referred for surgery, lead was extracted and a new epicardial lead was placed. The culture of
the extracted material was positive for Staphilococcus hominis. Antibiotherapy was continued
till the end of the postoperative sixth week accordingly. In conclusion, in patients with
pacemakers and risk factors for endocarditis, fever must suggest lead endocarditis and TEE
must be performed for accurate diagnosis. In addition to appropriate antibiotic therapy,
extraction of infected material is needed for the cure.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
Use of intracardiac devices for heart diseases is increasing
worldwide. The most frequently used implantable devices are
cardiac pacemakers. One of the important complications of
pacemakers is infective endocarditis from the leads as the
source. Clinical findings of leads endocarditis are more subtle
than that of native valve infective endocarditis and thus the
diagnosis is frequently delayed. Staphylococcus aureus and Staphy-
lococcus epidermidis are the most frequent causative agents
responsible for lead endocarditis within the first six months
after the implantation [1–3]. S. hominis is a natural habitant of thech Society of Cardiology.
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m (S. Ercan).human skin flora and rarely reported as a cause of device related
or prosthetic valve endocarditis [4]. In this case, we report a lead
endocarditis caused by S. hominis four years after the pacemaker
implantation and we will discuss the management of patients
with lead endocarditis.2. Case report
A 50 year-old diabetic woman, who was diagnosed with sick
sinus syndrome and implanted a permanent pacemaker four
years ago, had complaints of fever and fatigue three monthsPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
03928.
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antibiotic treatment. Her complaints persisted despite treat-
ment and she was admitted to infectious disease clinic and
consulted with cardiology. Physical examination was normal
except body temperature (38,5 1C) and tachycardia (110 bpm).
Laboratory values showed normal leukocyte count (WBC:
7800 10^3/mL) and increased levels of C-reactive protein
(CRP; 116 mg/L) and erythrocyte sedimentation rate (ESR;
70 mm/h). Other routine laboratory values were within nor-
mal limits.
Transthoracic echocardiography (TTE) showed a mass image
on the pacemaker lead. On transesophageal echocardiography
(TEE), a mobile mass resembling vegetation on the lead, around
the tricuspid valve with sparing the leaflets, which was
1510 mm in diameter was revealed (Fig. 1). The patient is
hospitalized, three sets of blood cultures were drawn and
vancomycin (2 gr daily) and gentamycin (160mg daily) were
started. Blood cultures were positive for S. aureus for two times.
Antibiogram showed that the microorganism was sensitive to
the treatment protocol and so the antibiotherapy was not
changed. However, at the end of the second week of treatment,
fever persisted and markers of inflammation (ESR and CRP)
remained elevated. Thus, the patient was referred for surgery,
lead was extracted and a new epicardial lead was placed. There
was no vegetation on tricuspid valve. The culture of the
extracted material was positive for S. hominis. Antibiotherapy
was appropriate according to the antibiogram and continued
till the end of the postoperative sixth week. On follow up, fever
did not recur, ESR was 14mm/h and CRP was 4mg/L. Control
TTE was negative for vegetation.3. Discussion
Prevalance of lead endocarditis in patients with cardiac pace-
makers is reported to be 0.5%–7% [3]. Apart from general
symptoms such as fever and malaise, peripheric clinical find-
ings of infective endocarditis are not observed frequently in
these patients; hence the diagnosis is especially hard, fre-
quently delayed and sometimes even missed. The average time
from symptom onset to diagnosis is 3–4 months. Risk factorsFig. 1 – Transesophageal echocardiography shows a mass (veget
lead of the pace, star: mass (vegetation).for cardiac pacemaker related infective endocarditis are dia-
betes, malignancy, cachexia, use of steroids and immunosup-
pressive treatment [3]. Our patient was diabetic and there had
been three months from symptom onset to diagnosis.
Lead endocarditis can be seen early or late after pacemaker
implantation. Early endocarditis is defined as occurring
within the first six months after implantation and causative
microorganisms are most likely S. aureus and S. epidermidis
[2,5]. Despite the fact that blood culture positivity in these
patients are less common than patients with native valve
endocarditis, Victor et al. [6] reported that blood cultures were
positive 85% of patients with vegetation. In our case, polimi-
crobial etiology was confirmed with positive blood cultures
for S. aureus and extracted lead material culture for S.
hominis. Review of the literature shows that only lead endo-
carditis caused by S. hominis was reported by Su¨nbu¨l et al. [4].
Furthermore, it is important to notice that endocarditis was
emerged very late after pacemaker implantation.
There are different suggestions for the diagnosis of lead
endocarditis but modified Duke Criteria are used, although
they are less specific than for native valve endocarditis [7]. In
addition, septic pulmonary emboli supports the diagnosis.
Our patient had both of the major criteria; blood culture
positivity and echocardiographic findings.
In these patients, fever is the predominant symptom, just
like in native valve endocarditis. Older and immunosuppres-
sive patients may come up with a more silent clinical picture.
Fever may emerge as subfebrile and sustained, or it can be
septic in nature due to sepsis and chills can be seen together.
In addition, by way of direct contact, the pacemaker gen-
erator site may become infected and local erythema, abscess,
fistula into the skin, purulent discharge and phlebitis in
associated veins may become evident [8,9].
Echocardiography is very important in the diagnosis of lead
endocarditis. However, reviews suggest that TTE is inade-
quate. Victor et al. [6] evaluated 23 patients with lead
endocarditis and found that TTE was capable of diagnosis
in only 30% of patients, whereas TEE was able to diagnose
91% of the patient population. Additionally TEE may give
detailed information about the tricuspid valve. A recent study
showed that concomitant valve infection is associated withation) on the lead. RA: right atria, RV: right ventriculi, arrow:
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 3 3 6 – e 3 3 8e338increased mortality [10]. Therefore, in patients with perma-
nent pacemaker, evaluation of fever should always include a
TEE examination.
Extraction of contamined material should be the corner-
stone of therapy in patients with lead endocarditis. Choo
et al. [5] suggested that without extracting the infected
material, the infection cannot be controlled even if correct
antibiotics are used according to antibiogram result. Our case
was also an example for this conclusion. Therefore, along
with appropriate antibiotic treatment, the extraction of
infected material is needed for therapy. There are two
different techniques for lead extraction. The first one is direct
percutaneous extraction and the other option is surgical
thoracotomy. Percutaneous technique can be used if the
vegetation is smaller than 10 milimeters and the tricuspid
valve is not involved, the time from implantation is shorter
than 1–2 years and the patient is not pacemaker dependent.
In other situations, surgical extraction and placement of a
epicardial lead must be considered [3,9].
In conclusion, in patients with pacemakers and risk factors
for endocarditis, fever must suggest lead endocarditis and
TEE must be performed for accurate diagnosis. In addition to
appropriate antibiotic therapy, extraction of infected material
is needed for the cure.
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